PORTFOLIO

Project presentations on the website

Every project supported by Gebert Rüf Stiftung is made accessible with a web presentation that informs about the core data of the project. With this public presentation, the foundation publishes the funding results achieved and contributes to the communication of science to society.

Close

UNOMR – Revolutionizing Proteomics with Nanopores

Editorial

The project management is responsible for the content of the information provided.

Project data

  • Project no: GRS-095/24 
  • Amount of funding: CHF 150'000 
  • Approved: 20.02.2025 
  • Duration: 06.2025 - 10.2026 
  • Area of activity:  InnoBooster, seit 2018

Project management

Project description

UNOMR, a techBio startup from ETH Zürich is pioneering single-molecule protein modification analysis through their innovative dynamic nanopore sensor. The current focus lies on the site-specific analysis of protein modifications with sugars, called glycosylation, which are aberrant in autoimmune diseases or epithelial tumors associated with breast or pancreatic cancer. Their patented solution has far-reaching applications across healthcare, pharmaceutical development, and food science, offering a powerful new tool for therapeutic discoveries and medical food innovation. Driven by the vision of bringing advanced proteomics directly to the patient, UNOMR aims to catalyze the next breakthrough in precision medicine by making sophisticated protein analysis accessible.

Status/Results

Goal of the project is to bring an existing prototype closer to an MVP. The sensor consists of two parts: 1) sensor hardware and 2) consumables based on silicon chips which need to be replaced regularly. Within the project the focus lies on the scale-up and improved reliability of the consumables. The design and casing of the silicon chip will be improved in the first half of the project.
We have a partnership with Nestlé to test the potential of single-protein glycosylation occupancy with our technology. Beyond the on-going project our focus is to show pharma and biotech industry the benefits of single-molecule proteomics and how it can help to solve some of their most urgent challenges these industry face.

Links

Persons involved in the project

Dr. Til Schlotter at ETH, at UNOMR, Co-founder & CEO, Project leader; application development, microfabrication, customer interaction, fundraising
Dr. Julian Hengsteler at ETH, at UNOMR, Co-founder & CTO, Co-project leader; engineering, sensor hardware, software, microfluidics, data analysis
Dr. Julia Wagner, Co-founder & COO; business, fundraising, legal, HR, opertions

Last update to this project presentation  03.04.2025